A detailed history of Wedmont Private Capital transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Wedmont Private Capital holds 38,626 shares of MRVI stock, worth $187,336. This represents 0.02% of its overall portfolio holdings.

Number of Shares
38,626
Previous 38,507 0.31%
Holding current value
$187,336
Previous $275,000 16.36%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$6.84 - $9.73 $813 - $1,157
119 Added 0.31%
38,626 $320,000
Q2 2024

Jul 15, 2024

SELL
$6.87 - $11.34 $27,012 - $44,588
-3,932 Reduced 9.27%
38,507 $275,000
Q1 2024

Apr 10, 2024

BUY
$5.11 - $8.76 $26,786 - $45,919
5,242 Added 14.09%
42,439 $367,000
Q4 2023

Jan 09, 2024

BUY
$4.7 - $9.87 $123,685 - $259,738
26,316 Added 241.85%
37,197 $243,000
Q3 2023

Oct 10, 2023

BUY
$9.14 - $12.85 $99,452 - $139,820
10,881 New
10,881 $108,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $638M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Wedmont Private Capital Portfolio

Follow Wedmont Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Wedmont Private Capital with notifications on news.